Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?

Background: Major depressive disorder is associated with inflammation and immune processes. Depressive symptoms correlate with inflammatory markers and alterations in the immune system including cytokine levels and immune cell function. Th17 cells are a T cell subset which exerts proinflammatory eff...

Full description

Bibliographic Details
Main Authors: Meiying Cui, Wanlin Dai, Jing Kong, Hongzhi Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.649144/full
_version_ 1818361811423985664
author Meiying Cui
Wanlin Dai
Jing Kong
Hongzhi Chen
author_facet Meiying Cui
Wanlin Dai
Jing Kong
Hongzhi Chen
author_sort Meiying Cui
collection DOAJ
description Background: Major depressive disorder is associated with inflammation and immune processes. Depressive symptoms correlate with inflammatory markers and alterations in the immune system including cytokine levels and immune cell function. Th17 cells are a T cell subset which exerts proinflammatory effects. Th17 cell accumulation and Th17/Treg imbalances have been reported to be critical in the pathophysiology of major depressive disorder and depressive-like behaviors in animal models. Th17 cells are thought to interfere with glutamate signaling, dopamine production, and other immune processes. Ketamine is a newly characterized antidepressant medication which has proved to be effective in rapidly reducing depressive symptoms. However, the mechanisms behind these antidepressant effects have not been fully elucidated.Method: Literature about Th17 cells and their role in depression and the antidepressant effect of ketamine are reviewed, with the possible interaction networks discussed.Result: The immune-modulating role of Th17 cells may participate in the antidepressant effect of ketamine.Conclusion: As Th17 cells play multiple roles in depression, it is important to explore the mechanisms of action of ketamine on Th17 cells and Th17/Treg cell balance. This provides new perspectives for strengthening the antidepressant effect of ketamine while reducing its side effects and adverse reactions.
first_indexed 2024-12-13T21:22:37Z
format Article
id doaj.art-3380a5a5a21c42f8943d81b3cef40a9e
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-13T21:22:37Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-3380a5a5a21c42f8943d81b3cef40a9e2022-12-21T23:31:03ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-04-011210.3389/fphar.2021.649144649144Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?Meiying Cui0Wanlin Dai1Jing Kong2Hongzhi Chen3Department of Anesthesiology, Shengjing Hospital, China Medical University, Shenyang, ChinaInnovation Institute of China Medical University, Shenyang, ChinaDepartment of General Surgery, Shengjing Hospital of China Medical University, Shenyang, ChinaDepartment of Anesthesiology, Shengjing Hospital, China Medical University, Shenyang, ChinaBackground: Major depressive disorder is associated with inflammation and immune processes. Depressive symptoms correlate with inflammatory markers and alterations in the immune system including cytokine levels and immune cell function. Th17 cells are a T cell subset which exerts proinflammatory effects. Th17 cell accumulation and Th17/Treg imbalances have been reported to be critical in the pathophysiology of major depressive disorder and depressive-like behaviors in animal models. Th17 cells are thought to interfere with glutamate signaling, dopamine production, and other immune processes. Ketamine is a newly characterized antidepressant medication which has proved to be effective in rapidly reducing depressive symptoms. However, the mechanisms behind these antidepressant effects have not been fully elucidated.Method: Literature about Th17 cells and their role in depression and the antidepressant effect of ketamine are reviewed, with the possible interaction networks discussed.Result: The immune-modulating role of Th17 cells may participate in the antidepressant effect of ketamine.Conclusion: As Th17 cells play multiple roles in depression, it is important to explore the mechanisms of action of ketamine on Th17 cells and Th17/Treg cell balance. This provides new perspectives for strengthening the antidepressant effect of ketamine while reducing its side effects and adverse reactions.https://www.frontiersin.org/articles/10.3389/fphar.2021.649144/fullketamineth17 celldepressionimmunecytokine
spellingShingle Meiying Cui
Wanlin Dai
Jing Kong
Hongzhi Chen
Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
Frontiers in Pharmacology
ketamine
th17 cell
depression
immune
cytokine
title Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
title_full Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
title_fullStr Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
title_full_unstemmed Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
title_short Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
title_sort th17 cells in depression are they crucial for the antidepressant effect of ketamine
topic ketamine
th17 cell
depression
immune
cytokine
url https://www.frontiersin.org/articles/10.3389/fphar.2021.649144/full
work_keys_str_mv AT meiyingcui th17cellsindepressionaretheycrucialfortheantidepressanteffectofketamine
AT wanlindai th17cellsindepressionaretheycrucialfortheantidepressanteffectofketamine
AT jingkong th17cellsindepressionaretheycrucialfortheantidepressanteffectofketamine
AT hongzhichen th17cellsindepressionaretheycrucialfortheantidepressanteffectofketamine